Overcoming the Tumor Microenvironment in Pancreatic Cancer via Barrier-Specific Nanoparticle Drug Delivery

J. Yang; Ryuji Kato; Jonghoon Choi

doi:10.1039/d5nr01067e

January 1, 2025Nanoscale

Overcoming the Tumor Microenvironment in Pancreatic Cancer via Barrier-Specific Nanoparticle Drug Delivery

View at Publisher

Ask AI

Bookmark

Share

Key Points

Enhanced drug delivery reduced the impact of metabolic stress in pancreatic cancer, leading to better outcomes.
Key evidence indicates that nanoparticle-based methods improve therapeutic penetration in the tumor microenvironment.
Analysis focused on the challenges posed by the tumor microenvironment and strategies to bypass these barriers effectively.
This approach highlights potential improvements in treatment success for pancreatic cancer, necessitating further validation in clinical settings.

Implication

Observational analysis demonstrates improved drug delivery in pancreatic cancer, suggesting nanoparticle strategies may enhance treatment efficacy.

Abstract

Pancreatic cancer is one of the most lethal malignancies, largely due to the formidable pathophysiological barriers presented by its tumor microenvironment (TME). These include metabolic stress, such as acidosis and...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68a36a480a429f797332ea8c https://doi.org/10.1039/d5nr01067e

View at Publisher

Ask AI

Bookmark

Share

Overcoming the Tumor Microenvironment in Pancreatic Cancer via Barrier-Specific Nanoparticle Drug Delivery

Key Points

Implication

Abstract

Discussion

Cite This Study

Overcoming the Tumor Microenvironment in Pancreatic Cancer via Barrier-Specific Nanoparticle Drug Delivery

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading